PAK1 and gastroesophageal junction adenocarcinoma: A cohort of GEJ adenocarcinomas (n = 20) assayed by immunoblot analysis demonstrated that 75% of GEJ adenocarcinoma tissues (15/20) showed higher PAK1 expression than in the adjacent noncancerous tissues (Figure 2A, P<0.001).